Skip to main content

913 (Erlotinib 25 mg)

Pill with imprint 913 is White, Round and has been identified as Erlotinib 25 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Erlotinib is used in the treatment of non-small cell lung cancer; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Erlotinib 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 913

Erlotinib 25 mg 913
Erlotinib 25 mg 913
Erlotinib 25 mg 913

Erlotinib

Imprint
913
Strength
25 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Egfr inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
70771-1521

Get help with Imprint Code FAQs.

Related Images for "913"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.